Carisma Therapeutics (CARM) Stock Research | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Company News

Competitive Advantages

Risks

Charts

Competitive Advantages

Risks

Over a week ago

ProKidney appoints Kenneth Locke as chief technical officer

PROK
CARM

|

Jun 2, 8:10 AM

Carisma Therapeutics announces Nasdaq delisting, SEC deregistration

CARM

|

Dec 5, 11:19 AM

No more stories

Carisma Therapeutics (CARM) Stock Research | The Fly